D46 Catégorie · précision supplémentaire requise Myelodysplastic syndromes
ICD-10-CM D46 identifies “Myelodysplastic syndromes” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapitre 2: Neoplasms
Instructions du code
Excludes 21
drug-induced aplastic anemia (D61.1)
Use additional code1
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Instructions des niveaux supérieurs
Chapitres 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
D37-D48 · Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)
Excludes 11
neoplasms of unspecified behavior (D49.-)
Note1
Categories D37-D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made.
Codes plus précis
D46.0Refractory anemia without ring sideroblasts, so statedCode facturable et spécifiqueD46.1Refractory anemia with ring sideroblastsCode facturable et spécifiqueD46.2Refractory anemia with excess of blasts [RAEB]Catégorie · précision supplémentaire requiseD46.4Refractory anemia, unspecifiedCode facturable et spécifiqueD46.9Myelodysplastic syndrome, unspecifiedCode facturable et spécifiqueD46.ARefractory cytopenia with multilineage dysplasiaCode facturable et spécifiqueD46.BRefractory cytopenia with multilineage dysplasia and ring sideroblastsCode facturable et spécifiqueD46.CMyelodysplastic syndrome with isolated del(5q) chromosomal abnormalityCode facturable et spécifiqueD46.ZOther myelodysplastic syndromesCode facturable et spécifiqueRéférences de l’index officiel
Références depuis d’autres codes (5)
Excludes 1 · myelodysplastic syndromes (D46.-)
Code also · myelodysplastic syndrome (D46.-)
Excludes 2 · pancytopenia (due to) (with) myelodysplastic syndromes (D46.-)
Excludes 1 · refractory anemia (D46.-)
Use additional code · code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
Historique
Historique du code
Aucune modification depuis la première observation
En vigueur dès le
- Première observation
Myelodysplastic syndromes
Catégorie — choisir un code plus précis
CDC/NCHS · FY2016Toutes les éditions (19)
| Toutes les éditions | En vigueur dès le | Historique du code |
|---|---|---|
| FY2016 | 2015-10-01 | Première observation |
| FY2017 | 2016-10-01 | Aucun changement tabulaire |
| FY2018 | 2017-10-01 | Aucun changement tabulaire |
| FY2019 | 2018-10-01 | Aucun changement tabulaire |
| FY2020 | 2019-10-01 | Aucun changement tabulaire |
| FY2020 · April | 2020-04-01 | Aucun changement tabulaire |
| FY2021 | 2020-10-01 | Aucun changement tabulaire |
| FY2021 · 01-01 | 2021-01-01 | Aucun changement tabulaire |
| FY2022 | 2021-10-01 | Aucun changement tabulaire |
| FY2022 · 04-01 | 2022-04-01 | Aucun changement tabulaire |
| FY2023 | 2022-10-01 | Aucun changement tabulaire |
| FY2023 · 04-01 | 2023-04-01 | Aucun changement tabulaire |
| FY2024 | 2023-10-01 | Aucun changement tabulaire |
| FY2024 · 04-01 | 2024-04-01 | Aucun changement tabulaire |
| FY2025 | 2024-10-01 | Aucun changement tabulaire |
| FY2025 · 04-01 | 2025-04-01 | Aucun changement tabulaire |
| FY2026 | 2025-10-01 | Aucun changement tabulaire |
| FY2026 · April | 2026-04-01 | Aucun changement tabulaire |
| FY2027 | 2026-10-01 | Aucun changement tabulaire |
Explorez les codes plus précis de cette catégorie. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.